const m=(e="")=>e==="pathogenesis"?i():e==="immunity"?t():e==="pathology"?n():e==="clinical-presentation"?o():e==="examination-findings"?a():e==="investigations"?s():e==="treatment"?r():e==="complications"?l():e==="kenya-context"?c():[{title:"Postpartum Endometriosis - Comprehensive Management",clickableItems:[{text:"ğŸ§¬ Pathogenesis of Postpartum Endometriosis",sectionId:"pathogenesis"},{text:"ğŸ›¡ï¸ Immunity Against Endometriosis",sectionId:"immunity"},{text:"ğŸ”¬ Pathology of Endometriosis",sectionId:"pathology"},{text:"ğŸ©º Clinical Presentation",sectionId:"clinical-presentation"},{text:"ğŸ‘©â€âš•ï¸ Examination Findings",sectionId:"examination-findings"},{text:"ğŸ” Investigations",sectionId:"investigations"},{text:"ğŸ’Š Treatment Options",sectionId:"treatment"},{text:"âš ï¸ Complications",sectionId:"complications"},{text:"ğŸ‡°ğŸ‡ª Kenya-Specific Considerations",sectionId:"kenya-context"}]},{title:"Postpartum Endometriosis Overview",points:["ğŸ“Š **Incidence**: 0.5-2% of postpartum women, higher in those with previous endometriosis","â° **Timeline**: Can develop 6-12 weeks postpartum, peak occurrence 3-6 months","ğŸ¯ **Risk Factors**: Previous endometriosis, cesarean section, episiotomy, operative delivery","ğŸ©º **Clinical Impact**: Chronic pelvic pain, dyspareunia, subfertility, psychological distress","ğŸ¥ **Healthcare Burden**: Increased healthcare utilization, diagnostic delays, treatment costs","ğŸ‘¶ **Impact on Future Pregnancies**: Reduced fertility, increased pregnancy complications","ğŸŒ **Global Perspective**: Underdiagnosed condition with significant quality of life impact"]},{title:"Management Summary - Quick Reference",points:["ğŸš¨ **Early Recognition**: High index of suspicion in women with cyclical pain post-delivery","ğŸ’Š **First-Line Treatment**: NSAIDs, hormonal contraceptives, progestins","ğŸ¥ **Surgical Intervention**: Reserved for failed medical therapy or large endometriomas","ğŸ”„ **Follow-up Care**: Regular monitoring, fertility counseling, psychological support","ğŸ‘¥ **Multidisciplinary Approach**: Gynecologist, pain specialist, fertility expert, counselor","ğŸ“š **Patient Education**: Disease understanding, treatment options, fertility implications","ğŸ¯ **Treatment Goals**: Pain relief, quality of life improvement, fertility preservation"]}],i=()=>[{title:"Pathogenesis of Postpartum Endometriosis",subsections:[{title:"Retrograde Menstruation Theory",points:["ğŸ’« **Sampson's Theory**: Retrograde flow of menstrual debris through fallopian tubes","ğŸŒŠ **Implantation Process**: Viable endometrial cells implant on peritoneal surfaces","ğŸ”„ **Postpartum Changes**: Altered uterine anatomy post-delivery may increase retrograde flow","âš¡ **Hormonal Influence**: Estrogen dominance promotes implantation and growth","ğŸ§¬ **Cellular Viability**: Endometrial cells maintain proliferative capacity outside uterus","ğŸ“ **Site Predilection**: Dependent pelvic areas, ovaries, uterosacral ligaments"]},{title:"Coelomic Metaplasia Theory",points:["ğŸ”¬ **Meyer's Theory**: Peritoneal mesothelium transforms into endometrial tissue","ğŸ§ª **Metaplastic Transformation**: Hormonal and inflammatory stimuli trigger transformation","ğŸŒ± **Embryologic Origin**: MÃ¼llerian duct and coelomic epithelium share common origin","âš—ï¸ **Molecular Triggers**: Growth factors, cytokines, steroid hormones","ğŸ”„ **Postpartum Environment**: Hormonal fluctuations may trigger metaplastic changes","ğŸ“Š **Evidence**: Explains endometriosis in women without menstruation"]},{title:"Vascular and Lymphatic Dissemination",points:["ğŸ©¸ **Hematogenous Spread**: Endometrial cells transported via blood vessels","ğŸ’§ **Lymphatic Transport**: Spread through lymphatic channels","ğŸ”„ **Postpartum Circulation**: Altered vascular patterns post-delivery","ğŸ¯ **Distant Sites**: Explains endometriosis in lungs, brain, extremities","âš¡ **Angiogenesis**: New blood vessel formation supports ectopic implants","ğŸ§¬ **Cellular Adhesion**: Endometrial cells adhere to vascular endothelium"]},{title:"Genetic and Epigenetic Factors",points:["ğŸ§¬ **Familial Clustering**: 7-10 fold increased risk in first-degree relatives","ğŸ“Š **Heritability**: Estimated 50% genetic contribution","ğŸ”¬ **Candidate Genes**: HOXA10, WNT4, KRAS, PIK3CA mutations","âš¡ **Epigenetic Changes**: DNA methylation, histone modifications","ğŸŒ± **Gene Expression**: Altered expression of steroid receptors, adhesion molecules","ğŸ”„ **Postpartum Modifications**: Pregnancy-induced epigenetic changes may persist"]},{title:"Immune System Dysfunction",points:["ğŸ›¡ï¸ **Immune Surveillance**: Defective clearance of ectopic endometrial cells","âš¡ **NK Cell Function**: Reduced natural killer cell activity","ğŸ”¬ **Macrophage Activation**: Alternatively activated macrophages promote growth","ğŸ’« **Autoimmune Component**: Anti-endometrial antibodies, molecular mimicry","ğŸŒŠ **Cytokine Imbalance**: Pro-inflammatory cytokine predominance","ğŸ”„ **Postpartum Immune Changes**: Pregnancy-induced immune tolerance may persist"]}]}],t=()=>[{title:"Immunity Against Endometriosis",subsections:[{title:"Innate Immune Response",points:["ğŸ›¡ï¸ **First Line Defense**: Peritoneal macrophages, NK cells, neutrophils","âš¡ **Pattern Recognition**: Toll-like receptors detect endometrial debris","ğŸ”¥ **Inflammatory Response**: Complement activation, cytokine release","ğŸ’« **Phagocytosis**: Macrophage clearance of ectopic endometrial cells","ğŸŒŠ **Barrier Function**: Peritoneal mesothelium prevents implantation","ğŸ”„ **Postpartum Changes**: Altered innate immunity post-delivery"]},{title:"Adaptive Immune Response",points:["ğŸ¯ **T Cell Responses**: Th1/Th2 balance shifts toward Th2 dominance","ğŸ§¬ **B Cell Activation**: Antibody production against endometrial antigens","âš¡ **Regulatory T Cells**: Increased Tregs promote immune tolerance","ğŸ”¬ **Antigen Presentation**: HLA class II expression on ectopic endometrium","ğŸ’« **Memory Responses**: Long-term immunological memory formation","ğŸŒ± **Immune Tolerance**: Pregnancy-induced tolerance may persist postpartum"]},{title:"Immune Evasion Mechanisms",points:["ğŸ­ **Molecular Mimicry**: Endometrial cells express anti-apoptotic proteins","ğŸ›¡ï¸ **Immune Privilege**: Local immunosuppressive microenvironment","âš¡ **Complement Resistance**: Expression of complement regulatory proteins","ğŸ”„ **Angiogenic Factors**: VEGF, FGF promote vascularization","ğŸŒŠ **Matrix Remodeling**: MMPs facilitate tissue invasion","ğŸ’« **Hormonal Modulation**: Estrogen suppresses immune surveillance"]},{title:"Inflammatory Mediators",points:["ğŸ”¥ **Pro-inflammatory Cytokines**: IL-1Î², TNF-Î±, IL-6 elevation","âš¡ **Chemokines**: MCP-1, RANTES attract inflammatory cells","ğŸŒŠ **Growth Factors**: PDGF, TGF-Î² promote fibrosis","ğŸ’« **Prostaglandins**: PGE2 causes pain and inflammation","ğŸ§¬ **Nuclear Factors**: NF-ÎºB activation drives inflammation","ğŸ”„ **Resolution Defects**: Impaired inflammatory resolution mechanisms"]}]}],n=()=>[{title:"Pathology of Postpartum Endometriosis",subsections:[{title:"Histological Features",points:["ğŸ”¬ **Classic Triad**: Endometrial glands, stroma, and hemosiderin-laden macrophages","ğŸŒ± **Glandular Architecture**: Pseudostratified epithelium with mitotic activity","ğŸ’« **Stromal Component**: Spindle-shaped cells with CD10 positivity","ğŸ©¸ **Hemorrhage**: Fresh and old blood, hemosiderin deposits","âš¡ **Inflammatory Infiltrate**: Lymphocytes, plasma cells, eosinophils","ğŸ”„ **Cyclic Changes**: Hormonal responsiveness similar to eutopic endometrium"]},{title:"Immunohistochemical Markers",points:["ğŸ¯ **CD10**: Positive in endometrial stroma","âš¡ **Estrogen Receptor**: Strong positivity in glands and stroma","ğŸ’« **Progesterone Receptor**: Variable expression, often reduced","ğŸ”¬ **Cytokeratin**: Positive in glandular epithelium","ğŸ§¬ **Ki-67**: Proliferation marker, higher in active lesions","ğŸŒŠ **Smooth Muscle Actin**: Positive in smooth muscle metaplasia"]},{title:"Macroscopic Appearance",points:["ğŸ”µ **Color Variation**: Blue-black, red, brown, white lesions","ğŸ“ **Size Range**: Few millimeters to several centimeters","ğŸ¯ **Distribution**: Ovaries, uterosacral ligaments, pouch of Douglas","ğŸ’« **Endometriomas**: Chocolate cysts with thick brown fluid","ğŸŒŠ **Adhesions**: Dense fibrous tissue, organ distortion","âš¡ **Surface Changes**: Puckering, scarring, nodular thickening"]},{title:"Special Variants",points:["ğŸ”¬ **Deep Infiltrating**: >5mm beneath peritoneal surface","ğŸ’« **Adenomyosis Externa**: Endometriosis involving muscle layers","ğŸŒ± **Microscopic Disease**: Histologically confirmed, macroscopically normal","âš¡ **Atypical Forms**: Hyperplastic, secretory, decidualized changes","ğŸ¯ **Malignant Transformation**: Rare progression to carcinoma","ğŸ”„ **Postpartum Variants**: Decidualized endometriosis, pregnancy-related changes"]}]}],o=()=>[{title:"Clinical Presentation of Postpartum Endometriosis",subsections:[{title:"Primary Symptoms",points:["âš¡ **Pelvic Pain**: Progressive, cyclical pain starting 2-3 months postpartum","ğŸ©¸ **Dysmenorrhea**: Severe menstrual pain with resumption of menses","ğŸ’” **Dyspareunia**: Deep pelvic pain during intercourse","ğŸš¶â€â™€ï¸ **Chronic Pelvic Pain**: Continuous aching, worse with activity","ğŸ¤° **Subfertility**: Difficulty conceiving subsequent pregnancies","ğŸ”„ **Cyclical Symptoms**: Pain pattern following menstrual cycle"]},{title:"Secondary Symptoms",points:["ğŸ’© **Bowel Symptoms**: Cyclical rectal bleeding, constipation, tenesmus","ğŸ’§ **Urinary Symptoms**: Dysuria, hematuria, frequency during menses","ğŸ¤¢ **Gastrointestinal**: Nausea, bloating, cyclical bowel changes","ğŸ˜´ **Fatigue**: Chronic exhaustion, sleep disturbances","ğŸ§  **Mood Changes**: Depression, anxiety, irritability","ğŸ”¥ **Fever**: Low-grade fever during active disease"]},{title:"Site-Specific Presentations",points:["ğŸ¥š **Ovarian**: Unilateral or bilateral ovarian masses, cyclical pain","ğŸŒŠ **Peritoneal**: Diffuse pelvic pain, adhesion-related symptoms","ğŸ’« **Deep Infiltrating**: Severe dyspareunia, rectovaginal nodularity","ğŸ« **Pulmonary**: Cyclical chest pain, pneumothorax during menses","ğŸ§  **CNS**: Cyclical headaches, seizures (rare)","ğŸ¦´ **Musculoskeletal**: Cyclical joint pain, muscle aches"]},{title:"Timing and Progression",points:["â° **Onset**: Typically 6-12 weeks postpartum with menses resumption","ğŸ“ˆ **Progression**: Gradual worsening over months to years","ğŸ”„ **Cyclical Pattern**: Symptoms correlate with menstrual cycle","ğŸ’Š **Response to Hormones**: Improvement with pregnancy or menopause","âš¡ **Acute Episodes**: Sudden severe pain with cyst rupture","ğŸ¥ **Emergency Presentations**: Ovarian torsion, hemoperitoneum"]}]}],a=()=>[{title:"Examination Findings in Postpartum Endometriosis",subsections:[{title:"General Examination",points:["ğŸ˜Ÿ **General Appearance**: Chronic pain facies, guarding behavior","ğŸ“Š **Vital Signs**: Usually normal, fever if complications present","ğŸ’” **Mood Assessment**: Signs of depression, anxiety, chronic pain syndrome","ğŸƒâ€â™€ï¸ **Functional Status**: Reduced activity tolerance, pain-related limitations","ğŸ’Š **Medication Effects**: Side effects from chronic pain medications","âš–ï¸ **Weight Changes**: Weight gain from hormonal treatments or inactivity"]},{title:"Abdominal Examination",points:["ğŸ¤² **Inspection**: Surgical scars (cesarean), abdominal distension","ğŸ‘‹ **Palpation**: Tenderness, masses, organ enlargement","ğŸµ **Percussion**: Ascites (rare), organ boundaries","ğŸ‘‚ **Auscultation**: Bowel sounds, vascular bruits","âš¡ **Trigger Points**: Specific areas of maximum tenderness","ğŸ”„ **Guarding**: Voluntary or involuntary muscle protection"]},{title:"Pelvic Examination",points:["ğŸ‘ï¸ **Inspection**: Vulvar lesions, vaginal endometriosis (rare)","ğŸ¤² **Speculum Exam**: Cervical endometriosis, vaginal fornix nodules","ğŸ‘ **Bimanual Exam**: Uterine size, mobility, adnexal masses","âš¡ **Cervical Motion**: Tenderness suggests pelvic adhesions","ğŸ’« **Uterosacral Ligaments**: Nodularity, thickening, tenderness","ğŸ¯ **Pouch of Douglas**: Obliteration, nodules, fixed ovaries"]},{title:"Rectovaginal Examination",points:["ğŸ” **Rectovaginal Septum**: Nodules, thickening, tenderness","ğŸ’« **Uterosacral Ligaments**: Better palpation of deep lesions","ğŸŒŠ **Pouch of Douglas**: Assessment of obliteration, adhesions","âš¡ **Rectal Involvement**: Mucosal irregularities, strictures","ğŸ¯ **Parametrial Assessment**: Lateral extension of disease","ğŸ”„ **Mobility Assessment**: Fixed versus mobile uterus"]},{title:"Special Examination Techniques",points:["ğŸ“± **Transvaginal Ultrasound**: Point-of-care assessment during exam","âš¡ **Provocative Tests**: Pain mapping during examination","ğŸ¯ **Sliding Sign**: Assessment of posterior compartment mobility","ğŸ’« **Water Contrast**: Enhance visualization of adhesions","ğŸ”„ **Functional Assessment**: Pain with movement, position changes","ğŸ“Š **Pain Scoring**: Standardized pain assessment tools"]}]}],s=()=>[{title:"Investigations for Postpartum Endometriosis",subsections:[{title:"First-Line Investigations",points:["ğŸ“± **Transvaginal Ultrasound**: First-line imaging for ovarian endometriomas","ğŸ©¸ **Complete Blood Count**: Rule out anemia from chronic bleeding","âš¡ **ESR/CRP**: Assess inflammatory markers","ğŸ’§ **Urinalysis**: Rule out urinary tract involvement","ğŸ§¬ **CA-125**: Elevated in 80% of cases, non-specific marker","ğŸ”¬ **Pregnancy Test**: Rule out pregnancy before treatment"]},{title:"Advanced Imaging",points:["ğŸ” **MRI Pelvis**: Gold standard for deep infiltrating endometriosis","ğŸ’« **CT Scan**: For suspected bowel or urinary tract involvement","ğŸ“± **3D Ultrasound**: Enhanced visualization of complex lesions","ğŸŒŠ **Contrast Studies**: Barium enema for bowel involvement","âš¡ **IVP/CT Urography**: For suspected urinary tract involvement","ğŸ¯ **Specialized MRI**: Diffusion-weighted, contrast-enhanced sequences"]},{title:"Laboratory Markers",points:["ğŸ”¬ **CA-125**: Baseline and monitoring marker","ğŸ’« **CA 19-9**: May be elevated in endometriosis","âš¡ **Anti-MÃ¼llerian Hormone**: Assess ovarian reserve","ğŸ§¬ **Inflammatory Markers**: IL-6, TNF-Î± in research settings","ğŸŒŠ **Hormonal Profile**: FSH, LH, estradiol, progesterone","ğŸ¯ **Autoantibodies**: Anti-endometrial antibodies (research)"]},{title:"Histological Diagnosis",points:["ğŸ”¬ **Laparoscopic Biopsy**: Gold standard for definitive diagnosis","ğŸ’« **Frozen Section**: Intraoperative confirmation","âš¡ **Immunohistochemistry**: CD10, ER, PR staining","ğŸŒ± **Special Stains**: Hemosiderin, smooth muscle markers","ğŸ¯ **Molecular Studies**: Gene expression profiling (research)","ğŸ”„ **Repeat Sampling**: May be needed for atypical presentations"]},{title:"Functional Assessment",points:["ğŸ“Š **Pain Assessment**: Visual analog scales, questionnaires","ğŸ’” **Quality of Life**: EHP-30, SF-36 questionnaires","ğŸ¤° **Fertility Assessment**: HSG, ovarian reserve testing","ğŸ§  **Psychological Evaluation**: Depression, anxiety screening","âš¡ **Functional Capacity**: Activity limitation assessment","ğŸ”„ **Treatment Response**: Monitoring tools for therapy effectiveness"]}]}],r=()=>[{title:"Treatment of Postpartum Endometriosis",subsections:[{title:"Medical Management - First Line",points:["ğŸ’Š **NSAIDs**: Ibuprofen 400mg TID, naproxen 250mg BID for pain","ğŸŒ™ **Combined OCPs**: Continuous use to suppress ovulation","âš¡ **Progestins**: Medroxyprogesterone 150mg IM q3months","ğŸ’« **Levonorgestrel IUS**: Mirena coil, local progestin effect","ğŸ”„ **GnRH Agonists**: Leuprolide 3.75mg IM monthly (max 6 months)","ğŸ¯ **Add-back Therapy**: Low-dose estrogen/progestin with GnRH agonists"]},{title:"Advanced Medical Therapy",points:["ğŸ§¬ **GnRH Antagonists**: Elagolix 150mg BID, fewer side effects","âš¡ **Aromatase Inhibitors**: Letrozole 2.5mg daily with progestins","ğŸ’« **Selective Progesterone Modulators**: Ulipristal acetate","ğŸŒŠ **Anti-angiogenic Agents**: Bevacizumab (research settings)","ğŸ”¬ **Immunomodulators**: Pentoxifylline, anti-TNF agents","ğŸ¯ **Novel Agents**: SERM/SPRM combinations under investigation"]},{title:"Surgical Management",points:["ğŸ” **Diagnostic Laparoscopy**: Confirm diagnosis, assess extent","âš¡ **Ablation/Excision**: Thermal ablation or complete excision","ğŸ’« **Ovarian Surgery**: Cystectomy for endometriomas >4cm","ğŸŒŠ **Deep Surgery**: Rectovaginal endometriosis excision","ğŸ¯ **Adhesiolysis**: Division of pelvic adhesions","ğŸ¥ **Hysterectomy**: Last resort for refractory cases"]},{title:"Fertility-Preserving Options",points:["ğŸ¤° **Conservative Surgery**: Preserve reproductive organs","âš¡ **ART Preparation**: Optimize before IVF treatment","ğŸ’« **Ovarian Reserve**: Monitor AMH, antral follicle count","ğŸŒ± **Fertility Counseling**: Discuss future pregnancy plans","ğŸ”„ **Repeated Procedures**: May require multiple interventions","ğŸ¯ **Timing Optimization**: Balance treatment and fertility goals"]},{title:"Supportive Care",points:["ğŸ§  **Pain Management**: Multimodal approach, specialist referral","ğŸ’†â€â™€ï¸ **Physiotherapy**: Pelvic floor therapy, exercise programs","ğŸ§˜â€â™€ï¸ **Psychological Support**: Counseling, support groups","ğŸ¥— **Nutritional Support**: Anti-inflammatory diet","ğŸ’Š **Complementary Medicine**: Acupuncture, herbal remedies","ğŸ“š **Patient Education**: Disease understanding, self-management"]}]}],l=()=>[{title:"Complications of Postpartum Endometriosis",subsections:[{title:"Maternal Complications - Immediate",points:["ğŸ©¸ **Ovarian Cyst Rupture**: Acute abdomen, hemoperitoneum","âš¡ **Ovarian Torsion**: Surgical emergency, ovarian loss risk","ğŸ’« **Bowel Obstruction**: Adhesions, strictures from deep disease","ğŸŒŠ **Ureteral Obstruction**: Hydronephrosis, renal dysfunction","ğŸ”¥ **Infection**: Secondary to surgical procedures","âš–ï¸ **Chronic Pain Syndrome**: Central sensitization, disability"]},{title:"Maternal Complications - Long-term",points:["ğŸ¤° **Subfertility**: Mechanical and functional causes","ğŸ’” **Dyspareunia**: Impact on sexual function, relationships","ğŸ§  **Mental Health**: Depression, anxiety, chronic pain disorders","âš•ï¸ **Treatment Side Effects**: Hormonal therapy complications","ğŸ¥ **Healthcare Utilization**: Increased medical visits, costs","ğŸ‘¥ **Social Impact**: Work disability, relationship strain"]},{title:"Reproductive Complications",points:["ğŸ¥š **Ovarian Reserve**: Decreased AMH, premature ovarian aging","ğŸ¤° **Pregnancy Complications**: Increased miscarriage risk","âš¡ **Ectopic Pregnancy**: Higher risk with tubal involvement","ğŸ’« **Placental Complications**: Placenta previa, accreta risk","ğŸŒŠ **Obstetric Outcomes**: Preterm birth, growth restriction","ğŸ”„ **Recurrence Risk**: Higher in subsequent pregnancies"]},{title:"Rare but Serious Complications",points:["ğŸ§¬ **Malignant Transformation**: 0.7-1% risk, mainly ovarian","ğŸ« **Thoracic Endometriosis**: Pneumothorax, hemoptysis","ğŸ§  **CNS Involvement**: Seizures, focal neurological deficits","ğŸ’‰ **Massive Hemorrhage**: From deep infiltrating lesions","ğŸ”ª **Surgical Complications**: Bowel injury, ureteral damage","âš¡ **Anesthetic Risks**: With repeated surgical procedures"]},{title:"Impact on Future Pregnancies",points:["ğŸ• **Time to Conception**: Prolonged time to achieve pregnancy","ğŸ¤° **Pregnancy Loss**: Increased first trimester miscarriage","âš¡ **Preterm Delivery**: Higher risk of spontaneous preterm birth","ğŸ’« **Growth Restriction**: Impaired placental function","ğŸŒŠ **Hypertensive Disorders**: Increased preeclampsia risk","ğŸ¥ **Cesarean Delivery**: Higher operative delivery rates"]}]}],c=()=>[{title:"Kenya-Specific Considerations for Postpartum Endometriosis",subsections:[{title:"Epidemiology in Kenya",points:["ğŸ“Š **Prevalence**: Estimated 5-10% of reproductive-age women","ğŸ¥ **Healthcare Access**: Limited specialist gynecology services","ğŸ’° **Economic Impact**: High treatment costs relative to income","ğŸ“ **Awareness Levels**: Low public and healthcare provider awareness","â° **Diagnostic Delays**: Average 7-10 years from symptom onset","ğŸŒ **Regional Variations**: Higher rates in urban versus rural areas"]},{title:"Healthcare System Challenges",points:["ğŸ¥ **Specialist Shortage**: Limited reproductive endocrinologists","ğŸ” **Diagnostic Limitations**: Limited access to MRI, laparoscopy","ğŸ’Š **Drug Availability**: Inconsistent supply of hormonal medications","ğŸ’° **Cost Barriers**: Most treatments not covered by NHIF","ğŸš— **Geographic Access**: Long distances to specialized centers","ğŸ“š **Training Needs**: Healthcare provider education requirements"]},{title:"Cultural and Social Factors",points:["ğŸ¤ **Stigma**: Cultural taboos around discussing reproductive health","ğŸ‘¥ **Family Dynamics**: Extended family involvement in healthcare decisions","ğŸ’” **Fertility Pressure**: High social value placed on childbearing","ğŸ™ **Traditional Medicine**: Preference for herbal treatments","ğŸ’° **Economic Priorities**: Healthcare competes with basic needs","ğŸ“š **Education**: Variable literacy levels affecting understanding"]},{title:"Management Adaptations",points:["ğŸ’Š **First-Line Options**: Focus on available, affordable medications","ğŸ¥ **Referral Pathways**: Clear guidelines for specialist referral","ğŸ“± **Telemedicine**: Remote consultation and follow-up options","ğŸ‘¥ **Task Shifting**: Training nurses, clinical officers in management","ğŸŒ± **Prevention Focus**: Emphasis on early detection and intervention","ğŸ“Š **Registry Development**: Patient tracking and outcome monitoring"]},{title:"Resource Optimization",points:["ğŸ’Š **Essential Medicines**: Ensure availability of basic hormonal treatments","ğŸ” **Imaging Protocols**: Optimize use of available ultrasound resources","ğŸ‘¨â€âš•ï¸ **Training Programs**: Continuing medical education initiatives","ğŸ’° **Cost-Effective Strategies**: Generic medications, simplified protocols","ğŸ¥ **Hub and Spoke Model**: Centralized expertise with satellite clinics","ğŸ“š **Patient Education**: Culturally appropriate information materials"]}]}];export{m as getPostpartumEndometriosisContent};
